2019 annual financial data
XTL Biopharmaceuticals 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,315.94%.
Operating income was -842,000 USD and net income was -1,347,000 USD.
Operating cash flow was -908,000 USD.
Get free XTL Biopharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 69,000 USD
- Operating income
- -842,000 USD
- Net income
- -1,347,000 USD
- Operating cash flow
- -908,000 USD